|
WO2021028597A1
|
|
Method of preparing a fruit-containing product
|
|
WO2020245311A2
|
|
Nutritional composition comprising 2'fucosyllactose and dietary butyrate
|
|
WO2020245313A1
|
|
Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
|
|
WO2020239996A1
|
|
Non-digestible oligosaccharides for decreased colonic protein fermentation
|
|
WO2020234226A1
|
|
Composition comprising vitamin a and non digestible oligosaccharides
|
|
WO2020229690A1
|
|
Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
|
|
WO2020229689A1
|
|
Fermented formula for improving intestinal development
|
|
WO2020148391A1
|
|
Fermented formula with non-digestible oligosaccharides for use in rotavirus induced infection
|
|
WO2020127695A1
|
|
Process for preparing an infant formula using freeze-drying
|
|
WO2020251350A1
|
|
Process for manufacturing an infant formula product with hydrolysed protein
|
|
WO2020251354A1
|
|
Extrusion process for making infant formula with large lipid globules
|
|
WO2020251352A1
|
|
Gas-injection extrusion for producing infant formula products
|
|
WO2020251353A1
|
|
Process for manufacturing a substantially lactose-free infant formula product
|
|
WO2020251351A1
|
|
Process for manufacturing a fermented infant formula product
|
|
AU2019272800A1
|
|
Biomarkers for improving nutrion for infants at risk
|
|
WO2020211939A1
|
|
Embossed can construction
|
|
WO2019193037A1
|
|
Nutritional composition for use in the prevention of dry skin
|
|
AU2019220341A1
|
|
Native whey protein for reducing allergy
|
|
CN111698993A
|
|
Fermentation formulations containing indigestible oligosaccharides
|
|
WO2019155044A1
|
|
Fermented formula with non-digestible oligosaccharides
|
